Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Healthwell Acquisition Corp. I Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Second Amendment to Business Combination Agreement, by and among Healthwell Acquisition Corp. I, Healthwell Acquisition Corp. I Sponsor LLC, HWEL Holdings Corp., HWEL Merger Sub Corp., 1412384 B.C. Unlimited Liability Company, 1412388 B.C. Ltd, Starton Therapeutics, Inc. and Kiriakos Charlie Perperidis"
08/01/2023 8-K Quarterly results
07/25/2023 8-K Quarterly results
07/25/2023 8-K Quarterly results
07/21/2023 8-K Quarterly results
07/10/2023 8-K Quarterly results
06/29/2023 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events  Interactive Data
06/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Presentation"
06/12/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma · FDA agrees to the planned Phase 1b study in second-line transplant ineligible patients in multiple myeloma · Treatment regimen will include Velcade® and dexamethasone and replace oral Revlimid® with STAR-LLD PARAMUS, N.J., June 12, 2023 – Starton Therapeutics Inc. , a clinical stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today provided updates on its Phase 1b STAR-LLD clinical trial of its investigational continuous delivery lenalidomide in multiple myeloma. The U.S. Food and Drug Administration notified the Company that it may proceed with the U.S.-based ..."
05/15/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "FIRST AMENDMENT TO BUSINESS COMBINATION AGREEMENT"
05/03/2023 8-K Quarterly results
04/27/2023 8-K Quarterly results
03/23/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note",
"Promissory Note"
11/15/2021 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
09/23/2021 8-K Quarterly results
08/11/2021 8-K Quarterly results
08/06/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy